Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Evidence for carrier-mediated efflux of dopamine from corpus striatum.

Liang NY, Rutledge CO.

Biochem Pharmacol. 1982 Aug 1;31(15):2479-84. No abstract available.

PMID:
7126258
2.
3.

Potentiation by reserpine of the inhibition by amphetamine of (3H)dopamine accumulation in the rat striatum.

Ross SB.

J Pharm Pharmacol. 1977 Jul;29(7):433-4. No abstract available.

PMID:
19583
4.

Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine.

Raiteri M, Cerrito F, Cervoni AM, Levi G.

J Pharmacol Exp Ther. 1979 Feb;208(2):195-202. No abstract available.

PMID:
216794
5.
7.

Feedback control of dopamine synthesis in dopaminergic terminals of the rat striatum.

Javoy F, Agid Y, Bouvet D, Glowinski J.

J Pharmacol Exp Ther. 1972 Sep;182(3):454-63. No abstract available.

PMID:
4403433
8.

Is drug inhibition of dopamine uptake a misinterpretation of in vitro experiments?

Bauman PA, Maitre L.

Nature. 1976 Dec 23-30;264(5588):789-90. No abstract available.

PMID:
1012321
9.

Release of endogenous dopamine from corpus striatum.

Meyerhoff JL, Kant GJ.

Life Sci. 1978 Oct 9;23(14):1481-6. No abstract available.

PMID:
713704
10.

Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine.

Niddam R, Arbilla S, Scatton B, Dennis T, Langer SZ.

Naunyn Schmiedebergs Arch Pharmacol. 1985 Apr;329(2):123-7.

PMID:
4010791
11.

Benztropine-induced release of dopamine from brain in vivo.

Goodale DB, Moore KE.

Neuropharmacology. 1975 Aug;14(8):585-9. No abstract available.

PMID:
1178116
12.

Increased acoplasmic transport of H3-dopamine in nigro-neostriatal neurons after reserpine.

Fibiger HC, McGeer EG.

Life Sci. 1973 Dec 1;13(11):1565-71. No abstract available.

PMID:
4588712
13.

Transport of dopamine in discrete areas of the striatum and of cerebral cortex in the rat.

Tassin JP, Blanc G, Stinus L, Berger B, Glowinski J, Thierry AM.

Adv Exp Med Biol. 1976;69:337-45. No abstract available.

PMID:
941742
14.

Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model.

Fischer JF, Cho AK.

J Pharmacol Exp Ther. 1979 Feb;208(2):203-9. No abstract available.

PMID:
762652
15.

Interaction between dopamine influx and efflux in rat striatal synaptosomes.

Schoemaker H, Nickolson VJ.

Life Sci. 1982 Nov 29;31(22):2455-61.

PMID:
7154845
16.

3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra.

Elverfors A, Pileblad E, Lagerkvist S, Bergquist F, Jonason J, Nissbrandt H.

J Neurochem. 1997 Oct;69(4):1684-92.

17.

Contribution of vesicular and cytosolic dopamine to the increased striatal dopamine efflux elicited by intrastriatal injection of dexamphetamine.

Watanabe S, Aono Y, Fusa K, Takada K, Saigusa T, Koshikawa N, Cools AR.

Neuroscience. 2005;136(1):251-7. Epub 2005 Sep 21.

PMID:
16181742
19.

Sub-second striatal dopamine release measured by in vivo voltammetry.

Stamford JA, Kruk ZL, Millar J.

Brain Res. 1986 Sep 3;381(2):351-5.

PMID:
3489507
20.

Properties of dopamine efflux from rat striatal tissue caused by amphetamine and p-hydroxyamphetamine.

Fischer JF, Cho AK.

Proc West Pharmacol Soc. 1976;19:179-82. No abstract available.

PMID:
995984

Supplemental Content

Support Center